Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, setup and range errors. Treatment simulations . We created treatment plans for 3, 5, and 7 beam directions for 5 oropharyngeal cancer patients. Hereby a simultaneous-integrated boost technique was used with a PTV margin of 5 mm, prescribing 66 Gy to the primary tumour and positive necklevels, and 54 Gy to the elective neck levels, to be delivered in 30 fractions. Homogeneous target doses were aimed at and doses to the salivary glands, swallowing muscles, spinal cord, brain stem, oral cavity, and unspecified tissues were minimized. An example of a dose distribution is shown in Fig. 1 . Then, 300 treatment simulations were performed while including various uncertainties. Anatomical uncertainties were taken into account by using two CT scans per patient, whereby we employed an in-house developed non-rigid registration method for dose accumulation. For setup errors an online setup-protocol was simulated, but non-rigid bony anatomy variations were simulated by rigid patient shifts. Range errors were taken into account by a relative shift in the HU's. For each simulated treatment fraction the dose was recalculated. DVH parameters (V95%, V107%, D98%, mean dose) were used to evaluate the obtained dose distributions.
Results. In
we show an example of a patient's simulated DVHs for the CTV 66 Gy (black), CTV 54 Gy (blue), parotis right (red) and larynx (green). The simulation parameters were here as follows. The HU's were shifted with -3% (overshoot). The setup error was simulated by changing the patient's position in each treatment simulation with a systematic shift (for each simulation drawn from a Gaussian with a sigma of 2.5 mm) and a random shift (for each fraction in each simulation drawn from a Gaussian with a sigma of 2.5 mm). To evaluate the anatomical changes, we used two CT scans, a planning CT and a CT taken after 46 Gy was delivered (with photons). In Fig.1 (right) the planned dose is displayed with solid thick lines, the 20 treatment simulations are displayed with thin solid lines, and the average of the treatment simulations is shown in dashed thick lines. For the settings in these simulations we found that setup, range and anatomical uncertainties can lead to large differences between the planned dose and the dose delivered. In table 1 we display the values of V95% and V107% for the high and low dose regions for our settings. Plans that included more beam directions were not more robust against errors (p>0.05). 
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